Australia's most trusted
source of pharma news
Wednesday, 25 February 2026
Posted 25 February 2026 AM
The race to launch the first oral SERD in Australia just got tighter, with A Menarini being dealt another blow to its reimbursement efforts.
Orserdu was quietly approved by the TGA, however, it is not currently listed on the ARTG, as the company has decided not to supply the medicine in Australia for the time being.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.